This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1983.
Company Filing History:
Years Active: 1983
Title: Peter A Robson: Innovator in Anxiolytic Compounds
Introduction
Peter A Robson is a notable inventor based in Upper Stratton, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel anxiolytic compounds. His work focuses on creating effective treatments for anxiety disorders.
Latest Patents
Robson holds a patent for "Imidazo[1,2-a]quinoline derivatives useful as anxiolytics." This patent describes novel imidazo[1,2-a]quinolines characterized by specific chemical structures. These compounds exhibit remarkable anxiolytic and hypnotic activities, making them valuable in therapeutic applications. The patent outlines the preparation of these compounds and their non-toxic, pharmaceutically acceptable acid addition salts.
Career Highlights
Peter A Robson is associated with Roussel Uclaf, a company known for its innovative pharmaceutical products. His work at the company has contributed to advancements in the treatment of anxiety disorders. Robson's dedication to research and development has positioned him as a key figure in his field.
Collaborations
Robson has collaborated with Alan C Barnes, enhancing the research and development efforts in their projects. Their partnership has led to significant advancements in the understanding and treatment of anxiety.
Conclusion
Peter A Robson's contributions to the field of pharmaceuticals, particularly through his patent on anxiolytic compounds, highlight his innovative spirit and commitment to improving mental health treatments. His work continues to influence the development of effective therapies for anxiety disorders.